Literature DB >> 21857253

Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.

Steven B Zeliadt1, Nishant K Sekaran, Elaine Y Hu, Christopher C Slatore, David H Au, Leah Backhus, Daniel Y Wu, Jeffrey Crawford, Gary H Lyman, David C Dale.   

Abstract

INTRODUCTION: Lung cancer is a leading cause of death in the United States and among veterans. This study compares patterns of diagnosis, treatment, and survival for veterans diagnosed with non-small cell lung cancer (NSCLC) using a recently established cancer registry for the Veterans Affairs Pacific Northwest Network with the Puget Sound Surveillance, Epidemiology, and End Results cancer registry.
METHODS: A cohort of 1715 veterans with NSCLC were diagnosed between 2000 and 2006, and 7864 men were diagnosed in Washington State during the same period. Demographics, tumor characteristics, initial surgical patterns, and survival across the two registries were evaluated.
RESULTS: Veterans were more likely to be diagnosed with stage I or II disease (32.8%) compared with the surrounding community (21.5%, p = 0.001). Surgical resection rates were similar for veterans (70.2%) and nonveterans (71.2%) older than 65 years with early-stage disease (p = 0.298). However, veterans younger than 65 years with early-stage disease were less likely to undergo surgical resection (83.3% versus 91.5%, p = 0.003). Because there were fewer late-stage patients among veterans, overall survival was better, although within each stage group veterans experienced worse survival compared with community patients. The largest differences were among early-stage patients with 44.6% 5-year survival for veterans compared with 57.4% for nonveterans (p = 0.004).
CONCLUSIONS: The use of surgical resection among younger veterans with NSCLC may be lower compared with the surrounding community and may be contributing to poorer survival. Cancer quality of care studies have primarily focused on patients older than 65 years using Medicare claims; however, efforts to examine care for younger patients within and outside the Department of Veterans Affairs are needed.

Entities:  

Mesh:

Year:  2011        PMID: 21857253     DOI: 10.1097/JTO.0b013e31822ada77

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


  11 in total

1.  Metabolic syndrome, dyslipidemia and prostate cancer recurrence after primary surgery or radiation in a veterans cohort.

Authors:  L C Macleod; L J Chery; E Y C Hu; S B Zeliadt; S K Holt; D W Lin; M P Porter; J L Gore; J L Wright
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-03-31       Impact factor: 5.554

2.  Appropriateness of Prostate Cancer Imaging among Veterans in a Delivery System without Incentives for Overutilization.

Authors:  Danil V Makarov; Elaine Y C Hu; Dawn Walter; R Scott Braithwaite; Scott Sherman; Heather T Gold; Xiao-Hua Andrew Zhou; Cary P Gross; Steven B Zeliadt
Journal:  Health Serv Res       Date:  2015-09-30       Impact factor: 3.402

3.  Metformin effects on biochemical recurrence and metabolic signaling in the prostate.

Authors:  Brian Winters; Stephen Plymate; Steven B Zeliadt; Sarah Holt; Xiaotun Zhang; Elaine Hu; Daniel W Lin; Colm Morrissey; Bryan Wooldridge; John L Gore; Michael P Porter; Jonathan L Wright
Journal:  Prostate       Date:  2015-07-22       Impact factor: 4.104

4.  Uptake of Video-Assisted Thoracoscopic Lung Resections Within the Veterans Affairs for Known or Suspected Lung Cancer.

Authors:  Amelia W Maiga; Stephen A Deppen; Jason Denton; Michael E Matheny; Erin A Gillaspie; Jonathan C Nesbitt; Eric L Grogan
Journal:  JAMA Surg       Date:  2019-06-01       Impact factor: 14.766

5.  Comparison between Veteran and Non-Veteran Populations with Clinical Stage I Non-Small Cell Lung Cancer Undergoing Surgery.

Authors:  Brendan T Heiden; Daniel B Eaton; Su-Hsin Chang; Yan Yan; Martin W Schoen; Mayank R Patel; Daniel Kreisel; Ruben G Nava; Bryan F Meyers; Benjamin D Kozower; Varun Puri
Journal:  Ann Surg       Date:  2021-05-11       Impact factor: 12.969

6.  Hyperglycemia and prostate cancer recurrence in men treated for localized prostate cancer.

Authors:  J L Wright; S R Plymate; M P Porter; J L Gore; D W Lin; E Hu; S B Zeliadt
Journal:  Prostate Cancer Prostatic Dis       Date:  2013-03-05       Impact factor: 5.554

7.  How Patients View Lung Cancer Screening. The Role of Uncertainty in Medical Decision Making.

Authors:  Marilyn M Schapira; Charu Aggarwal; Scott Akers; Jaya Aysola; Diana Imbert; Corey Langer; Charlie B Simone; Emily Strittmatter; Anil Vachani; Liana Fraenkel
Journal:  Ann Am Thorac Soc       Date:  2016-11

Review 8.  EMT, CTCs and CSCs in tumor relapse and drug-resistance.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Oncotarget       Date:  2015-05-10

Review 9.  Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system.

Authors:  Leah L Zullig; Christina D Williams; Alice G Fortune-Britt
Journal:  Cancer Manag Res       Date:  2015-01-14       Impact factor: 3.989

10.  Incidence of Neutropenia in Veterans Receiving Lung Cancer Chemotherapy: A Comparison of Administrative Coding and Electronic Laboratory Data.

Authors:  Sarah Knerr; Elaine Y Hu; Steven B Zeliadt
Journal:  EGEMS (Wash DC)       Date:  2017-03-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.